Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting.

Volk JE, Marcus JL, Phengrasamy T, Blechinger D, Nguyen DP, Follansbee S, Hare CB.

Clin Infect Dis. 2015 Nov 15;61(10):1601-3. doi: 10.1093/cid/civ778. Epub 2015 Sep 1.

2.

Analytic and clinical performance of cobas HPV testing in anal specimens from HIV-positive men who have sex with men.

Wentzensen N, Follansbee S, Borgonovo S, Tokugawa D, Sahasrabuddhe VV, Chen J, Lorey TS, Gage JC, Fetterman B, Boyle S, Sadorra M, Tang SD, Darragh TM, Castle PE.

J Clin Microbiol. 2014 Aug;52(8):2892-7. doi: 10.1128/JCM.03517-13. Epub 2014 Jun 4.

3.

Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco.

Liu A, Cohen S, Follansbee S, Cohan D, Weber S, Sachdev D, Buchbinder S.

PLoS Med. 2014 Mar 4;11(3):e1001613. doi: 10.1371/journal.pmed.1001613. eCollection 2014 Mar. No abstract available.

4.

Risk factors for anal HPV infection and anal precancer in HIV-infected men who have sex with men.

Schwartz LM, Castle PE, Follansbee S, Borgonovo S, Fetterman B, Tokugawa D, Lorey TS, Sahasrabuddhe VV, Luhn P, Gage JC, Darragh TM, Wentzensen N.

J Infect Dis. 2013 Dec 1;208(11):1768-75. doi: 10.1093/infdis/jit374. Epub 2013 Aug 1.

5.

Human papillomavirus genotype attribution and estimation of preventable fraction of anal intraepithelial neoplasia cases among HIV-infected men who have sex with men.

Sahasrabuddhe VV, Castle PE, Follansbee S, Borgonovo S, Tokugawa D, Schwartz LM, Lorey TS, LaMere BJ, Gage JC, Fetterman B, Boyle S, Sadorra M, Tang SD, Darragh TM, Wentzensen N.

J Infect Dis. 2013 Feb 1;207(3):392-401. doi: 10.1093/infdis/jis694. Epub 2012 Nov 16.

6.

A comparison of human papillomavirus genotype-specific DNA and E6/E7 mRNA detection to identify anal precancer among HIV-infected men who have sex with men.

Castle PE, Follansbee S, Borgonovo S, Tokugawa D, Schwartz LM, Lorey TS, LaMere B, Gage JC, Fetterman B, Darragh TM, Rodriguez AC, Wentzensen N.

Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):42-9. doi: 10.1158/1055-9965.EPI-12-0984. Epub 2012 Nov 15.

7.

Human papillomavirus genotyping, human papillomavirus mRNA expression, and p16/Ki-67 cytology to detect anal cancer precursors in HIV-infected MSM.

Wentzensen N, Follansbee S, Borgonovo S, Tokugawa D, Schwartz L, Lorey TS, Sahasrabuddhe VV, Lamere B, Gage JC, Fetterman B, Darragh TM, Castle PE.

AIDS. 2012 Nov 13;26(17):2185-92. doi: 10.1097/QAD.0b013e328359f255.

8.

Interrater agreement of anal cytology.

Darragh TM, Tokugawa D, Castle PE, Follansbee S, Borgonovo S, LaMere BJ, Schwartz L, Gage JC, Fetterman B, Lorey T, Wentzensen N.

Cancer Cytopathol. 2013 Feb;121(2):72-8. doi: 10.1002/cncy.21218. Epub 2012 Jul 18.

9.

Low rates of hepatitis screening and vaccination of HIV-infected MSM in HIV clinics.

Hoover KW, Butler M, Workowski KA, Follansbee S, Gratzer B, Hare CB, Johnston B, Theodore JL, Tao G, Smith BD, Chorba T, Kent CK; Evaluation Group for Adherence to STD and Hepatitis Screening.

Sex Transm Dis. 2012 May;39(5):349-53. doi: 10.1097/OLQ.0b013e318244a923.

PMID:
22504597
10.

A comparison of dacron versus Flocked nylon swabs for anal cytology specimen collection.

Gage JC, Ghosh A, Borgonovo S, Follansbee S, Wentzensen N, Gravitt PE, Grabe N, Lahrmann B, Castle PE.

Acta Cytol. 2011;55(4):364-7. doi: 10.1159/000329488. Epub 2011 Jul 22.

11.

STD screening of HIV-infected MSM in HIV clinics.

Hoover KW, Butler M, Workowski K, Carpio F, Follansbee S, Gratzer B, Hare B, Johnston B, Theodore JL, Wohlfeiler M, Tao G, Brooks JT, Chorba T, Irwin K, Kent CK; Evaluation Group for Adherence to STD and Hepatitis Screening.

Sex Transm Dis. 2010 Dec;37(12):771-6. doi: 10.1097/OLQ.0b013e3181e50058.

PMID:
20585275
12.

Virologic outcomes of changing enfuvirtide to raltegravir in HIV-1 patients well controlled on an enfuvirtide based regimen: 24-week results of the CHEER study.

Towner W, Klein D, Kerrigan HL, Follansbee S, Yu K, Horberg M.

J Acquir Immune Defic Syndr. 2009 Aug 1;51(4):367-73. doi: 10.1097/QAI.0b013e3181ae35de.

PMID:
19487951
13.

HIV-1 Protease and reverse-transcriptase mutations: correlations with antiretroviral therapy in subtype B isolates and implications for drug-resistance surveillance.

Rhee SY, Fessel WJ, Zolopa AR, Hurley L, Liu T, Taylor J, Nguyen DP, Slome S, Klein D, Horberg M, Flamm J, Follansbee S, Schapiro JM, Shafer RW.

J Infect Dis. 2005 Aug 1;192(3):456-65. Epub 2005 Jul 5.

14.

Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy.

Kantor R, Shafer RW, Follansbee S, Taylor J, Shilane D, Hurley L, Nguyen DP, Katzenstein D, Fessel WJ.

AIDS. 2004 Jul 23;18(11):1503-11.

15.

Abacavir expanded access program for adult patients infected with human immunodeficiency virus type 1.

Kessler HA, Johnson J, Follansbee S, Sension MG, Mildvan D, Sepulveda GE, Bellos NC, Hetherington SV.

Clin Infect Dis. 2002 Feb 15;34(4):535-42. Epub 2002 Jan 4.

PMID:
11797183
16.

The house is burning: an HIV clinician's view after 20 years.

Follansbee S.

Focus. 2001 Aug;16(9):1-5. No abstract available.

PMID:
11692445
17.

Fifth Conference on Retroviruses & Opportunistic Infections. Interview by Ron Baker.

Follansbee S, Deeks S, Bartnoff H.

Newsline People AIDS Coalit N Y. 1998 Mar:7-14.

PMID:
11367453
18.

Tolerance and pharmacokinetic interactions of rifabutin and azithromycin.

Hafner R, Bethel J, Standiford HC, Follansbee S, Cohn DL, Polk RE, Mole L, Raasch R, Kumar P, Mushatt D, Drusano G; DATRI 001B Study Group.

Antimicrob Agents Chemother. 2001 May;45(5):1572-7.

19.

Does use of potent antiretroviral therapy differ by health care setting?

Fessel J, Follansbee S, Hurley L, Klein D.

JAMA. 1999 May 12;281(18):1696-7. No abstract available.

PMID:
10328065
20.

Ritonavir and saquinavir combination therapy for the treatment of HIV infection.

Cameron DW, Japour AJ, Xu Y, Hsu A, Mellors J, Farthing C, Cohen C, Poretz D, Markowitz M, Follansbee S, Angel JB, McMahon D, Ho D, Devanarayan V, Rode R, Salgo M, Kempf DJ, Granneman R, Leonard JM, Sun E.

AIDS. 1999 Feb 4;13(2):213-24.

PMID:
10202827

Supplemental Content

Loading ...
Support Center